Coya Therapeutics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $243 | $251 | $3,959 | $3,564 |
Gross Profit | 243 | 251 | 3,959 | 3,557 |
EBITDA | -6,635 | -7,627 | -5,698 | -2,108 |
EBIT | -6,638 | -7,630 | -5,705 | -2,115 |
Net Income | -6,638 | -7,206 | -5,708 | -2,115 |
Net Change In Cash | 243 | 251 | 3,959 | 3,564 |
Free Cash Flow | -13,673,396 | -6,208 | -1,007 | -1,130 |
Cash | 43,181,002 | 50,724 | 46,822 | 28,129 |
Basic Shares | 23,457 | 22,644 | 16,730 | 16,732 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $7,945 | $3,554 | $6,002 | $0 |
Gross Profit | 7,918 | -8,311 | 500 | -4,412 |
EBITDA | -21,195 | -17,197 | -7,332 | -9,259 |
EBIT | -21,223 | -17,224 | -7,360 | -9,286 |
Net Income | -21,226 | -14,880 | -7,987 | -12,244 |
Net Change In Cash | 7,945 | 3,554 | 6,002 | 0 |
Free Cash Flow | -10,739 | -10,288 | -11,188 | -7,239 |
Cash | 46,822 | 38,339 | 32,626 | 5,933 |
Basic Shares | 16,730 | 15,239 | 10,164 | 9,947 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.28 |
2026-03-31 | -$0.31 |
2025-12-31 | -$0.34 |
2025-09-30 | -$0.13 |